STOCK TITAN

Veradigm Stock Price, News & Analysis

MDRX Nasdaq

Welcome to our dedicated page for Veradigm news (Ticker: MDRX), a resource for investors and traders seeking the latest updates and insights on Veradigm stock.

Veradigm (MDRX) delivers healthcare technology solutions that connect providers, payers, and patients through integrated data platforms. This news hub provides investors and industry professionals with essential updates on the company’s strategic initiatives and market position.

Access real-time announcements including earnings reports, product innovations, and partnership developments shaping the future of healthcare IT. Our curated collection ensures you stay informed about regulatory milestones, technology deployments, and leadership changes impacting Veradigm ecosystem.

Key updates cover advancements in clinical data interoperability, financial performance metrics, and operational efficiency solutions for healthcare organizations. Bookmark this page for streamlined access to press releases and analysis relevant to MDRX’s role in advancing connected care technologies.

Rhea-AI Summary

ConnectiveRx has partnered with Veradigm, a unit of Allscripts (NASDAQ: MDRX), to enhance patient access to prescription-related information. The three-year agreement, effective from March 1, 2021, allows ConnectiveRx to deliver electronic coupons to over 130 million patients via Allscripts’ EHR platforms. In 2020, over 200 million electronic prescriptions were processed through the Allscripts network. This partnership aims to improve medication adherence and awareness, benefiting both healthcare providers and patients.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.88%
Tags
partnership
-
Rhea-AI Summary

Allscripts Healthcare Solutions (NASDAQ: MDRX), along with MATTER, Microsoft, and the ARC Innovation Center at Sheba Medical Center, hosted a virtual pitch competition centered on innovative health IT solutions. In honor of Florence Nightingale's legacy, eight organizations presented ideas to enhance electronic health records and lessen nurses' workloads. DeepScribe won the challenge with its AI-powered medical scribe, receiving multiple benefits, including marketing support and opportunity to present its solution to experts. Allscripts emphasizes the importance of innovation in healthcare delivery.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.59%
Tags
none
-
Rhea-AI Summary

Allscripts Healthcare Solutions (NASDAQ: MDRX) has partnered with US Orthopedic Alliance (USOA) to enhance orthopedic practices across the nation. This collaboration aims to provide state-of-the-art technology solutions, improve EHR implementation, and foster community-wide connectivity with value-based care analytics. USOA, serving over 100 orthopedic surgeons and multiple facilities, will leverage Allscripts' expertise to create a scalable platform that enhances operational efficiency while prioritizing patient-centered care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.53%
Tags
partnership
Rhea-AI Summary

The Gippsland Health Alliance (GHA) is expanding its Allscripts Sunrise™ electronic health record (EHR) across Gippsland, Victoria. Phase 3 of the EHR Community Health project involves implementing the Sunrise Emergency Care module at four hospitals. Allscripts previously rolled out its Sunrise EHR at Latrobe Regional Hospital, enhancing health services across the region. The cloud-based system's efficiency supports GHA's goal to improve care quality. This expansion aligns with international best practices, aiming for a connected health community in the Gippsland region.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.18%
Tags
none
-
Rhea-AI Summary

Allscripts (NASDAQ: MDRX) announced that members of its management team will present at the 2021 J.P. Morgan Virtual Healthcare Conference on January 12 at 2:50 pm ET. The event will be accessible via a live webcast and replay on the Allscripts investor website under the "Events and Presentations" section. Allscripts is recognized as a leader in healthcare IT solutions, enhancing clinical, financial, and operational results by connecting caregivers and patients within an Open, Connected Community of Health.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.74%
Tags
conferences
-
Rhea-AI Summary

On December 31, 2020, Allscripts (NASDAQ: MDRX) completed the sale of its CarePort Health business to WellSky Corporation for $1.35 billion. CarePort is designed to assist hospitals and post-acute care providers in coordinating and transitioning patients through various care settings. This strategic move aligns with Allscripts' focus on enhancing its healthcare information technology solutions, aiming to improve clinical, financial, and operational outcomes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.76%
Tags
none
Rhea-AI Summary

Allscripts Healthcare Solutions (NASDAQ: MDRX) is enhancing its digital health solutions in response to the COVID-19 pandemic. The company is collaborating with federal health agencies and public health organizations to improve vaccine administration and reporting. Key features being delivered include order management, billing, and allergy tracking, all integrated within their EHR systems. Allscripts aims to optimize vaccination efforts, supporting clients in achieving higher coverage rates. This commitment underscores Allscripts' role as a trusted partner in healthcare advancement during the pandemic.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.56%
Tags
covid-19
-
Rhea-AI Summary

Allscripts Healthcare Solutions (NASDAQ: MDRX) announced the general availability of Sunrise 20.0, a comprehensive health platform integrating key services such as acute care, pharmacy, and revenue cycle management. The upgrade includes over 150 enhancements, user experience updates, and significant performance improvements. Key features include modern RxWriter, M*Modal integration, and financial manager updates. The platform is enhanced by Microsoft Azure, promising improved efficiency and patient outcomes. This release reflects Allscripts' commitment to meeting global client needs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.92%
Tags
none
-
Rhea-AI Summary

Allscripts Healthcare Solutions (NASDAQ: MDRX) announced an accelerated share repurchase (ASR) program totaling $200 million, partnering with JPMorgan Chase and Wells Fargo. This initiative signifies a commitment to shareholder value and reflects the company's strong liquidity and confidence in its long-term strategy. The initial share delivery is approximately 11.7 million shares, with the final number determined by the average price during the ASR term. Allscripts' remaining repurchase authorization stands at about $67 million after this action.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.02%
Tags
buyback
Rhea-AI Summary

Allscripts Healthcare Solutions (NASDAQ: MDRX) has partnered with the Nurse Heroes initiative to support nurses through scholarships for nursing education and career advancement. This collaboration underscores the urgency of addressing the projected shortage of one million nurses by 2022. The announcement coincides with a Thanksgiving Day virtual concert on NBC featuring notable entertainers, celebrating the contributions of nurses, particularly during the COVID-19 pandemic.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.88%
Tags
none

FAQ

What is the current stock price of Veradigm (MDRX)?

The current stock price of Veradigm (MDRX) is $4.4 as of May 1, 2025.

What is the market cap of Veradigm (MDRX)?

The market cap of Veradigm (MDRX) is approximately 484.4M.
Veradigm

Nasdaq:MDRX

MDRX Rankings

MDRX Stock Data

484.38M
104.76M
2.91%
40.9%
Health Information Services
Healthcare
Link
United States
Chicago